Benzofuran oxyethylamines as antidepressants and anxiolytics

Novel benzofuranoxyethylamines of the formula (1), in which R1, R2, R3, R4, m and n have the meanings indicated in Patent Claim ( 1 ), which have a strong affinity to the 5 HT1A receptors and/or 5HT1D receptors. The compounds inhibit serotonin reuptake, exhibit serotonin-agonistic and -antagonistic...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	HOLZEMANN GUENTER, BOTTCHER HENNING, LEIBROCK JOACHIM, SEYFRIED CHRISTOPH, SCHIEMANN KAI, HEINRICH TIMO, VAN AMSTERDAM CHRISOPH, BARTOSZYK GERD
Format:	Patent
Sprache:	eng
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Novel benzofuranoxyethylamines of the formula (1), in which R1, R2, R3, R4, m and n have the meanings indicated in Patent Claim ( 1 ), which have a strong affinity to the 5 HT1A receptors and/or 5HT1D receptors. The compounds inhibit serotonin reuptake, exhibit serotonin-agonistic and -antagonistic properties and are suitable as antidepressants, anxiolytics, antipsychotics, neuroleptics and/or antihypertonics.